Mirae Asset Global Investments Co., Ltd. - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$151,263
-18.5%
13,814
-1.4%
0.00%
Q2 2023$185,532
-11.7%
14,004
-9.3%
0.00%
Q1 2023$210,098
-3.4%
15,437
+38.6%
0.00%
-100.0%
Q4 2022$217,486
+2.6%
11,136
+0.1%
0.00%0.0%
Q3 2022$212,00011,1240.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$37,274,86415.53%
MPM BioImpact LLC 1,745,943$23,762,2846.17%
Saturn V Capital Management LP 480,653$6,541,6874.89%
Boxer Capital, LLC 2,154,058$29,3171.44%
RA Capital Management 4,417,259$60,118,8951.36%
Octagon Capital Advisors LP 596,000$8,111,5601.17%
BVF INC/IL 1,810,835$24,645,4640.90%
AlphaCentric Advisors LLC 63,000$857,4300.59%
Integral Health Asset Management, LLC 180,000$2,449,8000.49%
683 Capital Management, LLC 480,000$6,532,8000.49%
View complete list of ITEOS THERAPEUTICS INC shareholders